132 related articles for article (PubMed ID: 2987577)
21. Significance of hepatitis B surface antigen carriers in a cohort.
Iijima T; Nambu M
Trop Gastroenterol; 1988; 9(4):196-8. PubMed ID: 2851885
[No Abstract] [Full Text] [Related]
22. Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.
Iwai M; Kashiwadani M; Okuno T; Takino T; Ibata Y
Histochem J; 1988 May; 20(5):283-9. PubMed ID: 2850288
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
Ozyilkan E; Ozyilkan O; Firat D; Telatar H
Cancer; 1994 Apr; 73(7):2002-3. PubMed ID: 8137230
[No Abstract] [Full Text] [Related]
24. Localization of hepatitis B surface and core antigens in human hepatocellular carcinoma by immunoperoxidase methods. Replication of complete virions of carcinoma cells.
Suzuki K; Uchida T; Horiuchi R; Shikata T
Cancer; 1985 Jul; 56(2):321-7. PubMed ID: 2988742
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma and hepatitis B virus markers in Europe and U.S.A.
Lancet; 1979 Feb; 1(8113):433-4. PubMed ID: 84277
[No Abstract] [Full Text] [Related]
26. Lack of correlation between hepatitis B virus infection and the increasing incidence of primary liver cancer in Sweden.
Kaczynski J; Hansson G; Norkrans G; Wallerstedt S
Acta Oncol; 1991; 30(7):811-3. PubMed ID: 1662521
[TBL] [Abstract][Full Text] [Related]
27. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
Hirohashi S; Shimosato Y; Ino Y; Kishi K
J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
[TBL] [Abstract][Full Text] [Related]
28. [Effect of chronic hepatitis B virus DNA negative transformation and HBsAg clearance on the occurrence of hepatocellular carcinoma].
Zhou JL; Wang BQ; Shi YW; You H
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):831-833. PubMed ID: 31941236
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma.
Song C; Zhu J; Ge Z; Yu C; Tian T; Wang H; Han J; Shen H; Dai J; Lu J; Hu Z
Clin Gastroenterol Hepatol; 2019 May; 17(6):1204-1206. PubMed ID: 30114488
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus DNA and human hepatocellular carcinoma.
Brechot C; Wain-Hobson S; Pourcel C; Dejean A; Hadchouel M; Scotto J; Tiollais P
Prog Clin Biol Res; 1983; 132D():495-504. PubMed ID: 6314366
[No Abstract] [Full Text] [Related]
31. Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver.
Blumberg BS; London WT
Cancer; 1982 Dec; 50(11 Suppl):2657-65. PubMed ID: 6291743
[TBL] [Abstract][Full Text] [Related]
32. [Clinical picture and geographical pathology of non-B type hepatocellular carcinoma].
Yamada G; Mizuno M; Sakamoto Y; Nishihara T; Nagashima H
Nihon Shokakibyo Gakkai Zasshi; 1982 Jun; 79(6):1290-7. PubMed ID: 6290719
[No Abstract] [Full Text] [Related]
33. [A comparative study of HBV-associated liver diseases between Korea and western part of Japan].
Haratake J; Horie A; Lee SD; Jimi A; Yoshimura M
Gan No Rinsho; 1990 Feb; Spec No():313-7. PubMed ID: 2156093
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiology of hepatocellular carcinoma in Japanese population].
Tanaka H; Tsukuma H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():7-12. PubMed ID: 11762041
[No Abstract] [Full Text] [Related]
35. Demonstration of hepatitis B virus surface component in human hepatocellular cancer cells.
Nayak NC; Sachdeva R; Dhar A; Seth HN
Indian J Med Res; 1979 Jan; 69():161-7. PubMed ID: 218886
[No Abstract] [Full Text] [Related]
36. Primary liver cell carcinoma (PLCC) in the Northern Guinea Savanna of Nigeria.
Fakunle YM; Ajdukiewicz AB; Greenwood BM; Edington GM
Trans R Soc Trop Med Hyg; 1977; 71(4):335-7. PubMed ID: 74110
[TBL] [Abstract][Full Text] [Related]
37. Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma.
Chang MH; Chen DS
Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):511-7. PubMed ID: 10654916
[TBL] [Abstract][Full Text] [Related]
38. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
Chlumská A; Kautzner J
Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
[No Abstract] [Full Text] [Related]
39. Presence of hepatitis B surface antigen before primary hepatocellular carcinoma.
Nomura A; Stemmermann GN; Wasnich RD
JAMA; 1982 Apr; 247(16):2247-9. PubMed ID: 6279892
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan.
Akagi G; Furuya K; Otsuka H
Cancer; 1982 Feb; 49(4):678-82. PubMed ID: 6275977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
